Both in Pharmaceuticals
Standard BioTools vs SIGA Technologies
Over the past year LAB returned −47.0% and SIGA returned −63.4%; their daily moves had a correlation of 0.07.
LAB −47.0% SIGA −63.4%Growth of $1, one year, split-adjusted
| Metric | LAB | SIGA |
|---|---|---|
| Price | $0.6100 | $3.04 |
| Market cap | $240.8M | $218.4M |
| Today | −1.61% | −4.40% |
| 1 month | −16.2% | −9.3% |
| 6 months | −34.8% | −33.9% |
| Year to date | −52.3% | −50.2% |
| 1 year | −48.7% | −62.6% |
| Revenue growth (YoY) | −7.6% | −49.5% |
| Gross margin | 52.4% | 57.2% |
| Net margin | −133.1% | 30.4% |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | 4.1× |
| Net cash | $476.4M | $117.6M |
| Dividend yield | — | 19.74% |
| Volatility (60d) | 45.5% | 42.3% |
| Short % of float | 1.1% | 8.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).